{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:59:17Z","timestamp":1790859557224,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41418-026-01709-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:57:36Z","timestamp":1773741456000},"page":"1994-2006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BTAF1: a key regulator of DNA end resection and predictor of chemotherapy sensitivity in gastric cancer"],"prefix":"10.1038","volume":"33","author":[{"given":"Juan-Juan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Liang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hua","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-6304","authenticated-orcid":false,"given":"Run-Cong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ling","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-3138","authenticated-orcid":false,"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-4391","authenticated-orcid":false,"given":"Mu-Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"1709_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1158\/2159-8290.CD-16-0860","volume":"7","author":"JS Brown","year":"2017","unstructured":"Brown JS, O\u2019Carrigan B, Jackson SP, Yap TA. Targeting DNA repair in cancer beyond PARP inhibitors. Cancer Discov. 2017;7:20\u201337.","journal-title":"Cancer Discov"},{"key":"1709_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability\u2014an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1709_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071\u20138.","journal-title":"Nature"},{"key":"1709_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","volume":"18","author":"HH Chang","year":"2017","unstructured":"Chang HH, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017;18:495\u2013506.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1709_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47:497\u2013510.","journal-title":"Mol Cell"},{"key":"1709_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355:1152\u20138.","journal-title":"Science"},{"key":"1709_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","volume":"23","author":"FJ Groelly","year":"2023","unstructured":"Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M. Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2023;23:78\u201394.","journal-title":"Nat Rev Cancer"},{"key":"1709_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrc3342","volume":"12","author":"P Bouwman","year":"2012","unstructured":"Bouwman P, Jonkers J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat Rev Cancer. 2012;12:587\u201398.","journal-title":"Nat Rev Cancer"},{"key":"1709_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-cancerbio-030617-050232","volume":"3","author":"E Gogola","year":"2019","unstructured":"Gogola E, Rottenberg S, Jonkers J. Resistance to PARP inhibitors: lessons from preclinical models of BRCA-associated cancer. Annu Rev Cancer Biol. 2019;3:235\u201354.","journal-title":"Annu Rev Cancer Biol"},{"key":"1709_CR10","first-page":"219","volume":"62","author":"E Raderschall","year":"2002","unstructured":"Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res. 2002;62:219\u201325.","journal-title":"Cancer Res"},{"key":"1709_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmed.2010.10.009","volume":"17","author":"CX Ma","year":"2011","unstructured":"Ma CX, Janetka JW, Piwnica-Worms H. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med. 2011;17:88\u201396.","journal-title":"Trends Mol Med"},{"key":"1709_CR12","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869\u201383.","journal-title":"Oncogene"},{"key":"1709_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrc2607","volume":"9","author":"JL Nitiss","year":"2009","unstructured":"Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer. 2009;9:338\u201350.","journal-title":"Nat Rev Cancer"},{"key":"1709_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pili\u00e9","year":"2019","unstructured":"Pili\u00e9 PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16:81\u2013104.","journal-title":"Nat Rev Clin Oncol"},{"key":"1709_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1100-5","volume":"18","author":"L Bian","year":"2019","unstructured":"Bian L, Meng Y, Zhang M, Li D. MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment. Mol Cancer. 2019;18:169.","journal-title":"Mol Cancer"},{"key":"1709_CR16","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1074\/jbc.M808906200","volume":"284","author":"P Huertas","year":"2009","unstructured":"Huertas P, Jackson SP. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem. 2009;284:9558\u201365.","journal-title":"J Biol Chem"},{"key":"1709_CR17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.molcel.2016.10.017","volume":"64","author":"R Anand","year":"2016","unstructured":"Anand R, Ranjha L, Cannavo E, Cejka P. Phosphorylated CtIP functions as a co-factor of the MRE11-RAD50-NBS1 endonuclease in DNA end resection. Mol Cell. 2016;64:940\u201350.","journal-title":"Mol Cell"},{"key":"1709_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm3047","volume":"12","author":"TH Stracker","year":"2011","unstructured":"Stracker TH, Petrini JH. The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol. 2011;12:90\u2013103.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1709_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nature10515","volume":"479","author":"V Garcia","year":"2011","unstructured":"Garcia V, Phelps SE, Gray S, Neale MJ. Bidirectional resection of DNA double-strand breaks by Mre11 and Exo1. Nature. 2011;479:241\u20134.","journal-title":"Nature"},{"key":"1709_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32920-x","volume":"13","author":"T Zhang","year":"2022","unstructured":"Zhang T, Yang H, Zhou Z, Bai Y, Wang J, Wang W. Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin. Nat Commun. 2022;13:5133.","journal-title":"Nat Commun"},{"key":"1709_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1146\/annurev-genet-071719-020312","volume":"55","author":"P Cejka","year":"2021","unstructured":"Cejka P, Symington LS. DNA end resection: mechanism and control. Annu Rev Genet. 2021;55:285\u2013307.","journal-title":"Annu Rev Genet"},{"key":"1709_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cell.2018.11.024","volume":"176","author":"RD Jachimowicz","year":"2019","unstructured":"Jachimowicz RD, Beleggia F, Isensee J, Velpula BB, Goergens J, Bustos MA, et al. UBQLN4 represses homologous recombination and is overexpressed in aggressive tumors. Cell. 2019;176:505\u201319.e22.","journal-title":"Cell"},{"key":"1709_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41418-022-01100-1","volume":"30","author":"A Belmonte-Fern\u00e1ndez","year":"2023","unstructured":"Belmonte-Fern\u00e1ndez A, Herrero-Ru\u00edz J, Galindo-Moreno M, Lim\u00f3n-Mort\u00e9s MC, Mora-Santos M, S\u00e1ez C, et al. Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy\/lysosomal pathway. Cell Death Differ. 2023;30:488\u201399.","journal-title":"Cell Death Differ"},{"key":"1709_CR24","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-16-3232","volume":"77","author":"J Nicholson","year":"2017","unstructured":"Nicholson J, Jevons SJ, Groselj B, Ellermann S, Konietzny R, Kerr M, et al. E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer. Cancer Res. 2017;77:3027\u201339.","journal-title":"Cancer Res"},{"key":"1709_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26413-6","volume":"12","author":"M Sanchez-Bailon","year":"2021","unstructured":"Sanchez-Bailon M, Choi S, Dufficy E, Sharma K, McNee G, Gunnell E, et al. Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair. Nat Commun. 2021;12:6313.","journal-title":"Nat Commun"},{"key":"1709_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/cr.2011.128","volume":"22","author":"Z Yu","year":"2012","unstructured":"Yu Z, Vogel G, Coulombe Y, Dubeau D, Spehalski E, H\u00e9bert J, et al. The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation. Cell Res. 2012;22:305\u201320.","journal-title":"Cell Res"},{"key":"1709_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294\u2013311.e21.","journal-title":"Cell"},{"key":"1709_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s43018-022-00429-3","volume":"3","author":"X Zeng","year":"2022","unstructured":"Zeng X, Zhao F, Cui G, Zhang Y, Deshpande RA, Chen Y, et al. METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma. Nat Cancer. 2022;3:1088\u2013104.","journal-title":"Nat Cancer"},{"key":"1709_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.molcel.2019.06.023","volume":"75","author":"Y Bai","year":"2019","unstructured":"Bai Y, Wang W, Li S, Zhan J, Li H, Zhao M, et al. C1QBP promotes homologous recombination by stabilizing MRE11 and controlling the assembly and activation of the MRE11\/RAD50\/NBS1 complex. Mol Cell. 2019;75:1299\u20131314.e6.","journal-title":"Mol Cell"},{"key":"1709_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203884","volume":"10","author":"W Liu","year":"2023","unstructured":"Liu W, Zheng M, Zhang R, Jiang Q, Du G, Wu Y, et al. RNF126-mediated MRE11 ubiquitination activates the DNA damage response and confers resistance of triple-negative breast cancer to radiotherapy. Adv Sci. 2023;10:2203884.","journal-title":"Adv Sci"},{"key":"1709_CR31","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1128\/MCB.18.3.1701","volume":"18","author":"JJ Chicca","year":"1998","unstructured":"Chicca JJ, Auble DT, Pugh BF. Cloning and biochemical characterization of TAF-172, a human homolog of yeast Mot1. Mol Cell Biol. 1998;18:1701\u201310.","journal-title":"Mol Cell Biol"},{"key":"1709_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(03)00714-5","volume":"315","author":"LA Pereira","year":"2003","unstructured":"Pereira LA, Klejman MP, Timmers HTM. Roles for BTAF1 and Mot1p in dynamics of TATA-binding protein and regulation of RNA polymerase II transcription. Gene. 2003;315:1\u201313.","journal-title":"Gene"},{"key":"1709_CR33","doi-asserted-by":"publisher","first-page":"21802","DOI":"10.1074\/jbc.M313519200","volume":"279","author":"LA Pereira","year":"2004","unstructured":"Pereira LA, Klejman MP, Ruhlmann C, Kavelaars F, Oulad-Abdelghani M, Timmers HTM, et al. Molecular architecture of the basal transcription factor B-TFIID. J Biol Chem. 2004;279:21802\u20137.","journal-title":"J Biol Chem"},{"key":"1709_CR34","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1093\/nar\/gki850","volume":"33","author":"MP Klejman","year":"2005","unstructured":"Klejman MP, Zhao X, van Schaik FM, Herr W, Timmers HTM. Mutational analysis of BTAF1-TBP interaction: BTAF1 can rescue DNA-binding defective TBP mutants. Nucleic Acids Res. 2005;33:5426\u201336.","journal-title":"Nucleic Acids Res"},{"key":"1709_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07432","volume":"4","author":"A Butryn","year":"2015","unstructured":"Butryn A, Schuller JM, Stoehr G, Runge-Wollmann P, F\u00f6rster F, Auble DT, et al. Structural basis for recognition and remodeling of the TBP:DNA:NC2 complex by Mot1. eLife. 2015;4:e07432.","journal-title":"eLife"},{"key":"1709_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2119\/molmed.2010.00103","volume":"17","author":"MY Cai","year":"2011","unstructured":"Cai MY, Hou JH, Rao HL, Luo RZ, Li M, Pei XQ, et al. High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients. Mol Med. 2011;17:12\u201320.","journal-title":"Mol Med"},{"key":"1709_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2020.05.040","volume":"182","author":"M Olivieri","year":"2020","unstructured":"Olivieri M, Cho T, \u00c1lvarez-Quil\u00f3n A, Li K, Schellenberg MJ, Zimmermann M, et al. A genetic map of the response to DNA damage in human cells. Cell. 2020;182:481\u201396.e21.","journal-title":"Cell"},{"key":"1709_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1042\/bj3450521","volume":"345","author":"JA van der Knaap","year":"2000","unstructured":"van der Knaap JA, van den Boom V, Kuipers J, van Eijk MJ, van der Vliet PC, Timmers HTM. The gene for human TATA-binding-protein-associated factor (TAFII) 170: structure, promoter and chromosomal localization. Biochem J. 2000;345:521\u20137.","journal-title":"Biochem J"},{"key":"1709_CR39","doi-asserted-by":"publisher","first-page":"11827","DOI":"10.1073\/pnas.94.22.11827","volume":"94","author":"JA van der Knaap","year":"1997","unstructured":"van der Knaap JA, Borst JW, van der Vliet PC, Gentz R, Timmers HTM. Cloning of the cDNA for the TATA-binding protein-associated factorII170 subunit of transcription factor B-TFIID reveals homology to global transcription regulators in yeast and Drosophila. Proc Natl Acad Sci USA. 1997;94:11827\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1709_CR40","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1128\/MCB.21.21.7523-7534.2001","volume":"21","author":"LA Pereira","year":"2001","unstructured":"Pereira LA, van der Knaap JA, van den Boom V, van den Heuvel FA, Timmers HTM. TAFII170 interacts with the concave surface of TATA-binding protein to inhibit its DNA binding activity. Mol Cell Biol. 2001;21:7523\u201334.","journal-title":"Mol Cell Biol"},{"key":"1709_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cr.2008.1","volume":"18","author":"X Li","year":"2008","unstructured":"Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008;18:99\u2013113.","journal-title":"Cell Res"},{"key":"1709_CR42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrm.2017.53","volume":"18","author":"A Ray Chaudhuri","year":"2017","unstructured":"Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017;18:610\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1709_CR43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1101\/gad.334516.119","volume":"34","author":"D Slade","year":"2020","unstructured":"Slade D. PARP and PARG inhibitors in cancer treatment. Genes Dev. 2020;34:360\u201394.","journal-title":"Genes Dev"},{"key":"1709_CR44","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1093\/bioinformatics\/bty159","volume":"34","author":"M Lo Monte","year":"2018","unstructured":"Lo Monte M, Manelfi C, Gemei M, Corda D, Beccari AR. ADPredict: ADP-ribosylation site prediction based on physicochemical and structural descriptors. Bioinformatics. 2018;34:2566\u201374.","journal-title":"Bioinformatics"},{"key":"1709_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nature10760","volume":"481","author":"CJ Lord","year":"2012","unstructured":"Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481:287\u201394.","journal-title":"Nature"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01709-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:31:50Z","timestamp":1790857910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01709-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01709-6","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Institutional Review Board approval (Sun Yat-sen University Cancer Center) the protocol (B2023-335-01) and informed consent were obtained prior to tissue acquisition and analysis. Animal ethics are listed in the Materials and Methods section.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}